Cited by 45Metabolism, Diabetes, and CancerCancer and biochemical researchHepatocellular Carcinoma Treatment and Prognosis

Preventive effect of Metformin against N-nitrosodiethylamine-initiated hepatocellular carcinoma in rats

Open access
Afzal, Muhammad, Kazmi, Imran, Gupta, Gaurav, Rahman, Mahfoozur, Kimothi, Vishwadeepak, Anwar, Firoz·2012·Saudi Pharmaceutical Journal

Abstract

Effect of Metformin in chemically induced hepatocarcinogenesis was assessed in Wistar rats. Intraperitoneal administration of chemical carcinogen diethyl nitrosamine (DENA) (200 mg/kg) in single dose elevated the levels of serum glutamate oxaloacetate transaminase (SGOT), serum glutamate pyruvate transaminase (SGPT), alkaline phosphatase (ALP), total cholesterol (TC), triglycerides (TG) and reduced high density lipoproteins (HDL), total proteins (TPR) and blood glucose level in tested animals. Histopathological examinations of the liver tissue showed marked carcinogenicity of the chemical carcinogen. Food and water intake, animal weights and serum albumin (ALB) were also assessed. The animals exposed to DENA showed a significant decrease in the body weights and, there were no significant alterations found in the total bilirubin (TBR) levels and gamma-glutamyltranspeptidase (GGTP), whereas the decreased levels of serum ALB were maintained by Metformin treatment. The elevated levels of serum SGOT, SGPT, ALP, AFP, TC and TG were restored by administration of Metformin in reduced dose (125 mg/kg) daily for 16 weeks p.o. Physiological and biochemical analysis showed the beneficial effects of Metformin in the animals exposed to DENA.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jsps.2012.05.012

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Llovet, J.M., Burroughs, A., Bruix, J., 2003. Hepatocellular carci- noma. Lancet 362 (9399), 1907-1917.

Cited by

Sorted by citations

Authors
Afzal, M., Kazmi, I., Gupta, G., Rahman, M., Kimothi, V., & Anwar, F.
Corresponding author
Anwar, Firoz
Venue
Saudi Pharmaceutical Journal
Published
2012-10
Volume
20
Issue
4
Pages
365-370
ISSN
1319-0164 (ISSN-L)
OpenAlex
W1982096716
Cited by
45
References
37
Citations by year
2025: 2 · 2024: 7 · 2023: 3 · 2022: 1 · 2021: 2 · 2020: 1 · 2019: 9 · 2018: 4 · 2017: 8 · 2016: 1 · 2015: 4 · 2014: 2 · 2013: 1
FWCI
0.90
Type
journal article
Language
en
Open access
Locations
  • Saudi Pharmaceutical Journal (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
  • Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
Keywords
metformin, hepatocellular carcinoma, diethylnitrosamine, preventive effect, liver enzymes, serum albumin, liver histopathology, anticancer activity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review